No Data
Information on individual stocks.
Chordi<190A.T> has sharply fallen. A notification was received from Ono Pharmaceutical<4528.T>, the licensee of the 'CTX-177 (ONO-7018)', which is an inhibitor of the translocation protein associated with mucosal-related lymphoid tissue lymphoma, stating that development is to be discontinued for strategic reasons, and the rights will be returned to the company. Sea U C<9158.T> declined significantly for the fourth consecutive day, hitting a year-to-date low. The consolidated net profit for the fiscal year ending March 2025 was announced to be 3.131 billion yen (previously
Haibu Techno has entered into a business partnership agreement with FAKES.
Hybe Techno <4260.T> announced on the 28th that it has reached an agreement to form a business partnership with FAKE (Shibuya, Tokyo) for the establishment of a joint proposal system for clients looking to launch services. FAKE provides product strategies and experience design based on business understanding. Through this partnership, a comprehensive offering will be provided, integrating FAKE's strengths in product strategy and UI/UX design with the company's strengths in agile system development, enhancing competitive advantage through the MVP development.
Kakaku.com ETC [Stocks with intriguing potential seen from Volume changes]
Closing price comparison with the previous day Volume * <9776> Sapporo 100,552,198,400 * <9240> Delivery Consultant 34,512,550,700 * <6074> JSS 41,514,134,400 * <6822> Oi Electric 273,219,884,000 * <3758> Aeria 25,124,654,400 * <4260> Hybrid Tech 46,769,202,300 * <7140> Petgo 89,129,135,400 * <4076> C.N.S 151,413,269,400 * <3
Hybrid Technologies: Revised Extraordinary Report
Hybrid Technologies: Presentation of financial results for the 1st quarter of the fiscal year ending 2025/9
Hybrid Technologies: Summary of financial results for the 1st quarter of the fiscal year ending 2025/9 [IFRS] (consolidated)
